表紙
市場調查報告書
商品編碼
974896

血液凝固能力檢驗的全球市場 (2017-2025年):產業分析、市場趨勢、市場佔有率、成長預測

Hemostasis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球血液凝固能力檢驗的市場調查,市場定義和概要,市場成長的各種影響因素分析,疫情趨勢,法規、償付方案,市場規模的變化、預測,檢驗類型、產品類型、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 序文

第2章 假設、調查手法

第3章 摘要整理

第4章 市場概要

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場分析、預測

第5章 重要考察

  • 凝固障礙與凝固途徑:概要
  • 疫情趨勢
  • 法律規範
  • 償付方案
  • 價格分析
  • 價值鏈分析
  • 波特的五力分析

第6章 市場分析、預測:各產品類型

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 實驗室系統
    • 消耗品
    • POC (照護現場) 檢驗系統
  • 市場魅力

第7章 市場分析、預測:各試驗類型

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 凝血素原試驗時間 (PT)
    • 活化部分凝血活酵素時間 (APTT)
    • 纖維蛋白原分解物產 (FDP)
    • 活性化凝固時間 (ACT)
    • 血小板凝集實驗
    • D-二聚體
    • 其他
  • 市場魅力

第8章 市場分析、預測:各終端用戶

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 醫院、診所
    • 獨立型診斷實驗室
    • 居家照護
    • 其他
  • 市場魅力

第9章 市場分析、預測:各地區

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力

第10章 北美市場分析、預測:各主要國家

第11章 歐洲市場分析、預測:各主要國家

第12章 亞太地區市場分析、預測:各主要國家

第13章 南美市場分析、預測:各主要國家

第14章 中東、非洲市場分析、預測:各主要國家

第15章 競爭情形

  • 競爭矩陣
  • 企業的佔有率、地位
  • 競爭事業策略
  • 企業簡介
    • Abbott Laboratories, Inc.
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Nihon Kohden Corporation
    • Sysmex Corporation
    • Siemens Healthineers
    • Instrumentation Laboratory
    • Danaher Corporation (Beckman Coulter)
    • Grifols, SA
目錄
Product Code: TMRGL1503

Title:
Hemostasis Diagnostics Market (Product Type - Laboratory Systems, Consumables, and Point-of-Care Testing Systems; Test Type - Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer; End Users - Hospital/Clinics, Independent Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Hemostasis Diagnostics Market - Scope of Report

TMR's report on the global hemostasis diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global hemostasis diagnostics market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hemostasis diagnostics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global hemostasis diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Hemostasis Diagnostics Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hemostasis diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hemostasis diagnostics market.

The report delves into the competitive landscape of the global hemostasis diagnostics market. Key players operating in the global hemostasis diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hemostasis diagnostics market that have been profiled in this report.

Key Questions Answered in Global Hemostasis Diagnostics Market Report

What is the scope of growth of product companies in the global hemostasis diagnostics market?

What will be the Y-o-Y growth of the global hemostasis diagnostics market between 2019 and 2027?

What is the influence of changing trends in technologies on the global hemostasis diagnostics market?

Will North America continue to be the most profitable market for hemostasis diagnostics devices providers?

Which factors are anticipated to hamper the growth of the global hemostasis diagnostics market during the forecast period?

Which are the leading companies in the global hemostasis diagnostics market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global hemostasis diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global hemostasis diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the hemostasis diagnostics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hemostasis diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hemostasis diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global hemostasis diagnostics market more reliably and accurately.

Regional Segmentation of Hemostasis Diagnostics Market

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemostasis Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Hemostasis Diagnostics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Coagulation Disorders & Coagulation Pathways: Overview
  • 5.2. Epidemiology: Coagulation Disorders
  • 5.3. Regulatory Framework
  • 5.4. Reimbursement Scenario
  • 5.5. Hemostasis Diagnostics Market: Pricing Analysis
  • 5.6. Hemostasis Diagnostics Market: Value Chain Analysis
  • 5.7. Hemostasis Diagnostics Market: Porter's Five Forces Analysis

6. Global Hemostasis Diagnostics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Hemostasis Diagnostics Market Value Forecast, by Product Type, 2017-2027
    • 6.2.1. Laboratory Systems
      • 6.2.1.1. Automated Systems
      • 6.2.1.2. Semi-automated Systems
      • 6.2.1.3. Manual Systems
    • 6.2.2. Consumables
    • 6.2.3. Point-of-Care Testing Systems
  • 6.3. Global Hemostasis Diagnostics Market Attractiveness, by Product Type

7. Global Hemostasis Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Hemostasis Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 7.2.1. Prothrombin Test Time (PT)
    • 7.2.2. Activated partial thromboplastin time (APTT)
    • 7.2.3. Fibrinogen degradation products (FDP)
    • 7.2.4. Activated Clotting Time
    • 7.2.5. Platelet Aggregation Test
    • 7.2.6. D Dimer
    • 7.2.7. Others
  • 7.3. Global Hemostasis Diagnostics Market Attractiveness, by Test Type

8. Global Hemostasis Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
    • 8.1.1. Key Findings / Developments
  • 8.2. Global Hemostasis Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 8.2.1. Hospital/Clinics
    • 8.2.2. Independent Diagnostic Laboratories
    • 8.2.3. Home Care Settings
    • 8.2.4. Others
  • 8.3. Global Hemostasis Diagnostics Market Attractiveness, by End-user

9. Global Hemostasis Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Hemostasis Diagnostics Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. North America Hemostasis Diagnostics Market Attractiveness, by Region

10. North America Hemostasis Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
    • 10.2.1. Laboratory Systems
      • 10.2.1.1. Automated Systems
      • 10.2.1.2. Semi-automated Systems
      • 10.2.1.3. Manual Systems
    • 10.2.2. Consumables
    • 10.2.3. Point-of-Care Testing Systems
  • 10.3. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 10.3.1. Prothrombin Test Time (PT)
    • 10.3.2. Activated partial thromboplastin time (APTT)
    • 10.3.3. Fibrinogen degradation products (FDP)
    • 10.3.4. Activated Clotting Time
    • 10.3.5. Platelet Aggregation Test
    • 10.3.6. D Dimer
    • 10.3.7. Others
  • 10.4. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 10.4.1. Hospital/Clinics
    • 10.4.2. Independent Diagnostic Laboratories
    • 10.4.3. Home Care Settings
    • 10.4.4. Others
  • 10.5. North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Hemostasis Diagnostics Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Test Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Hemostasis Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
    • 11.2.1. Laboratory Systems
      • 11.2.1.1. Automated Systems
      • 11.2.1.2. Semi-automated Systems
      • 11.2.1.3. Manual Systems
    • 11.2.2. Consumables
    • 11.2.3. Point-of-Care Testing Systems
  • 11.3. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 11.3.1. Prothrombin Test Time (PT)
    • 11.3.2. Activated partial thromboplastin time (APTT)
    • 11.3.3. Fibrinogen degradation products (FDP)
    • 11.3.4. Activated Clotting Time
    • 11.3.5. Platelet Aggregation Test
    • 11.3.6. D Dimer
    • 11.3.7. Others
  • 11.4. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 11.4.1. Hospital/Clinics
    • 11.4.2. Independent Diagnostic Laboratories
    • 11.4.3. Home Care Settings
    • 11.4.4. Others
  • 11.5. Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Hemostasis Diagnostics Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Test Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Hemostasis Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
    • 12.2.1. Laboratory Systems
      • 12.2.1.1. Automated Systems
      • 12.2.1.2. Semi-automated Systems
      • 12.2.1.3. Manual Systems
    • 12.2.2. Consumables
    • 12.2.3. Point-of-Care Testing Systems
  • 12.3. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 12.3.1. Prothrombin Test Time (PT)
    • 12.3.2. Activated partial thromboplastin time (APTT)
    • 12.3.3. Fibrinogen degradation products (FDP)
    • 12.3.4. Activated Clotting Time
    • 12.3.5. Platelet Aggregation Test
    • 12.3.6. D Dimer
    • 12.3.7. Others
  • 12.4. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 12.4.1. Hospital/Clinics
    • 12.4.2. Independent Diagnostic Laboratories
    • 12.4.3. Home Care Settings
    • 12.4.4. Others
  • 12.5. Asia Pacific Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Test Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Hemostasis Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
    • 13.2.1. Laboratory Systems
      • 13.2.1.1. Automated Systems
      • 13.2.1.2. Semi-automated Systems
      • 13.2.1.3. Manual Systems
    • 13.2.2. Consumables
    • 13.2.3. Point-of-Care Testing Systems
  • 13.3. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 13.3.1. Prothrombin Test Time (PT)
    • 13.3.2. Activated partial thromboplastin time (APTT)
    • 13.3.3. Fibrinogen degradation products (FDP)
    • 13.3.4. Activated Clotting Time
    • 13.3.5. Platelet Aggregation Test
    • 13.3.6. D Dimer
    • 13.3.7. Others
  • 13.4. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 13.4.1. Hospital/Clinics
    • 13.4.2. Independent Diagnostic Laboratories
    • 13.4.3. Home Care Settings
    • 13.4.4. Others
  • 13.5. Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America Latin America
  • 13.6. Latin America Hemostasis Diagnostics Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Test Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Hemostasis Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
    • 14.2.1. Laboratory Systems
      • 14.2.1.1. Automated Systems
      • 14.2.1.2. Semi-automated Systems
      • 14.2.1.3. Manual Systems
    • 14.2.2. Consumables
    • 14.2.3. Point-of-Care Testing Systems
  • 14.3. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 14.3.1. Prothrombin Test Time (PT)
    • 14.3.2. Activated partial thromboplastin time (APTT)
    • 14.3.3. Fibrinogen degradation products (FDP)
    • 14.3.4. Activated Clotting Time
    • 14.3.5. Platelet Aggregation Test
    • 14.3.6. D Dimer
    • 14.3.7. Others
  • 14.4. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 14.4.1. Hospital/Clinics
    • 14.4.2. Independent Diagnostic Laboratories
    • 14.4.3. Home Care Settings
    • 14.4.4. Others
  • 14.5. Middle East & Africa Hemostasis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Test Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 15.2. Market Share / Position Analysis, by Company, 2018
  • 15.3. Competitive Business Strategies
  • 15.4. Company Profiles
    • 15.4.1. Abbott Laboratories, Inc.
      • 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.1.2. Financial Analysis
      • 15.4.1.3. Growth Strategies
      • 15.4.1.4. SWOT Analysis
    • 15.4.2. Thermo Fisher Scientific, Inc
      • 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.2.2. Financial Analysis
      • 15.4.2.3. Growth Strategies
      • 15.4.2.4. SWOT Analysis
    • 15.4.3. F. Hoffmann-La Roche Ltd
      • 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.3.2. Financial Analysis
      • 15.4.3.3. Growth Strategies
      • 15.4.3.4. SWOT Analysis
    • 15.4.4. Nihon Kohden Corporation
      • 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.4.2. Financial Analysis
      • 15.4.4.3. Growth Strategies
      • 15.4.4.4. SWOT Analysis
    • 15.4.5. Sysmex Corporation
      • 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.5.2. Financial Analysis
      • 15.4.5.3. Growth Strategies
      • 15.4.5.4. SWOT Analysis
    • 15.4.6. Siemens Healthineers
      • 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.6.2. Financial Analysis
      • 15.4.6.3. Growth Strategies
      • 15.4.6.4. SWOT Analysis
    • 15.4.7. Instrumentation Laboratory
      • 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.7.2. Financial Analysis
      • 15.4.7.3. Growth Strategies
      • 15.4.7.4. SWOT Analysis
    • 15.4.8. Danaher Corporation (Beckman Coulter)
      • 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.8.2. Financial Analysis
      • 15.4.8.3. Growth Strategies
      • 15.4.8.4. SWOT Analysis
    • 15.4.9. Grifols, S.A.
      • 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.9.2. Growth Strategies
      • 15.4.9.3. SWOT Analysis

List of Table

  • Table 01: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 03: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 04: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Region, 2019-2027
  • Table 05: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 06: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019-2027
  • Table 07: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019-2027
  • Table 08: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 09: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 10: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019-2027
  • Table 11: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019-2027
  • Table 12: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 13: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 14: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2019-2027
  • Table 15: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019-2027
  • Table 16: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 17: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017-2027
  • Table 18: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 19: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019-2027
  • Table 20: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 21: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017-2027
  • Table 22: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 23: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2019-2027
  • Table 24: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figure

  • Figure 01: Hemostasis Diagnostics Market Snapshot
  • Figure 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2027
  • Figure 03: Market Value Share By Product (2018)
  • Figure 04: Market Value Share By End-user (2018)
  • Figure 05: Market Value Share By Region(2018)
  • Figure 06: Global Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 07: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laboratory Systems, 2017-2027
  • Figure 08: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2017-2027
  • Figure 09: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Point-of-care Testing Systems, 2017-2027
  • Figure 10: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Systems, 2017-2027
  • Figure 11: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Semi-automated Systems, 2017-2027
  • Figure 12: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Manual Systems, 2017-2027
  • Figure 13: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Product
  • Figure 14: Global Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 15: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prothrombin Time (PT), 2017-2027
  • Figure 16: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT, 2017-2027
  • Figure 17: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fibrinogen Degradation Products (FDP), 2017-2027
  • Figure 18: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Activated Clotting Time, 2017-2027
  • Figure 19: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Platelet Aggregation Test, 2017-2027
  • Figure 20: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by D Dimer, 2017-2027
  • Figure 21: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 22: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
  • Figure 23: Global Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 24: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital & Clinics, 2017-2027
  • Figure 25: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Diagnostic Laboratories, 2017-2027
  • Figure 26: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care Settings, 2017-2027
  • Figure 27: Global Hemostasis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 28: Global Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 29: Global Hemostasis Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 30: Global Hemostasis Diagnostics Market Attractiveness Analysis, by Region
  • Figure 31: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 32: North America Hemostasis Diagnostics Market Attractiveness Analysis, by Country
  • Figure 33: North America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 34: North America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 35: North America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 36: North America Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 37: North America Hemostasis Diagnostics Market Attractiveness, by Product
  • Figure 38: North America Hemostasis Diagnostics Market Attractiveness, by Test Type
  • Figure 39: North America Hemostasis Diagnostics Market Attractiveness, by End-user
  • Figure 40: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 41: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Country
  • Figure 42: Europe Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 43: Europe Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 44: Europe Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 45: Europe Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 46: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Product
  • Figure 47: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
  • Figure 48: Europe Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 49: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017- 2027
  • Figure 50: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Country 2019-2027
  • Figure 51: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 52: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 53: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 54: Asia Pacific Hemostasis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 55: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Product
  • Figure 56: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
  • Figure 57: Asia Pacific Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 58: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 59: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 60: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 61: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 62: Latin America Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 63: Latin America Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 64: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Product
  • Figure 65: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
  • Figure 66: Latin America Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 67: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2017-2027
  • Figure 68: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Country/Sub-region
  • Figure 69: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 70: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 71: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 72: Middle East & Africa Hemostasis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 73: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Product
  • Figure 74: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by Test Type
  • Figure 75: Middle East & Africa Hemostasis Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 76: Global Hemostasis Diagnostics Market Share Analysis, by Company (2018)